Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 1 hour ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR9547Referred to Committee

To direct the Secretary of Defense to submit to Congress a report on emerging investigational treatment options for treatment-resistant post-traumatic stress disorder in veterans, members of the Armed Forces, and members transitioning to civilian life, and for other purposes.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-06-30
Introduced
3
Cosponsors
HR
ⓘ
Type

Sponsor

Abraham J. Hamadeh
Abraham J. Hamadeh
Republican · AZ · Representative
Votes with party: 95.9% (582 recorded votes)

Full profile: /officials/H001098

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Dan Crenshaw (R-TX-2)Original· 2026-06-30
  • Don Bacon (R-NE-2)Original· 2026-06-30
  • Seth Moulton (D-MA-6)Original· 2026-06-30

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Armed Services.

2026-06-30

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Armed ServicesReferred To · 2026-06-30

Plain-English Summary

The Department of Defense would be required to study and report to Congress on new experimental treatments for post-traumatic stress disorder (PTSD) that don't respond to standard therapies, focusing on what's available for veterans, active-duty military members, and those leaving the military. This report would help lawmakers understand what cutting-edge treatment options exist and how accessible they are to service members struggling with severe PTSD. The goal is to identify promising new approaches that could help veterans who haven't found relief through conventional treatment methods.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR9465Combat Pay Protection Act
    Referred to Committee · 2026-06-25
  • HR9241No Equipment Left Behind Act of 2026
    Referred to Committee · 2026-06-10
  • HR9242No American Left Behind Act
    Referred to Committee · 2026-06-10
  • HR8481Kayleigh’s Law Act of 2026
    Referred to Committee · 2026-06-03